Clinical trials
Respiratory Insufficiency trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
89 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 6 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 9 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 7 |
| 2023 | 6 |
| 2024 | 10 |
| 2025 | 12 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 36 |
| Unknown status | 28 |
| Recruiting | 19 |
| Not yet recruiting | 5 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Southeast University, China | 10 |
| Beijing Chao Yang Hospital | 5 |
| Peking Union Medical College Hospital | 5 |
| The First Affiliated Hospital of Guangzhou Medical University | 4 |
| Guangzhou Institute of Respiratory Disease | 3 |
| Ruijin Hospital | 3 |
| West China Hospital | 3 |
| Yun Long | 3 |
| Zhejiang University | 3 |
| Chongqing Medical University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Respiratory Insufficiency | 89 |
| Pulmonary Disease, Chronic Obstructive | 13 |
| Critical Illness | 10 |
| Respiratory Distress Syndrome | 8 |
| Hypoxia | 6 |
| Sepsis | 5 |
| Shock | 4 |
| Acute Lung Injury | 3 |
| Pancreatitis | 3 |
| Postoperative Complications | 3 |
Trials
Showing 76 to 89 of 89. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.